H.C. Wainwright Reiterates Buy Rating on Caribou Biosciences Inc. (CRBU)
Tweet Send to a Friend
H.C. Wainwright analyst Robert Burns reiterated a Buy rating and $3.00 price target on Caribou Biosciences Inc. (NASDAQ: CRBU).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
